Published in Glia on August 01, 1998
Gamma interferon primes productive human immunodeficiency virus infection in astrocytes. J Virol (2006) 1.07
CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice. J Neuroimmune Pharmacol (2008) 1.02
Response of cell cycle proteins to neurotrophic factor and chemokine stimulation in human neuroglia. Exp Neurol (2001) 0.89
Cerebrospinal fluid metabolomics implicate bioenergetic adaptation as a neural mechanism regulating shifts in cognitive states of HIV-infected patients. AIDS (2015) 0.83
Neuronal PINCH is regulated by TNF-α and is required for neurite extension. J Neuroimmune Pharmacol (2010) 0.82
Soluble factors from IL-1β-stimulated astrocytes activate NR1a/NR2B receptors: implications for HIV-1-induced neurodegeneration. Biochem Biophys Res Commun (2010) 0.82
Immortalization of primary microglia: a new platform to study HIV regulation in the central nervous system. J Neurovirol (2016) 0.81
Pseudomonas DING proteins as human transcriptional regulators and HIV-1 antagonists. Virol J (2013) 0.79
YY1 and FoxD3 regulate antiretroviral zinc finger protein OTK18 promoter activation induced by HIV-1 infection. J Neuroimmune Pharmacol (2008) 0.78
In vitro activation of feline immunodeficiency virus in ramified microglial cells from asymptomatically infected cats. J Virol (2001) 0.76
Calpain and proteasomal regulation of antiretroviral zinc finger protein OTK18 in human macrophages: visualization in live cells by intramolecular FRET. J Neuroimmune Pharmacol (2008) 0.75
Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol (1988) 4.96
Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet (1999) 4.20
Detection of hepatitis B virus DNA in serum by a simple spot hybridization technique: comparison with results for other viral markers. Hepatology (1983) 3.11
Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. Proc Natl Acad Sci U S A (1992) 2.98
Antibody response in primary human immunodeficiency virus infection. Lancet (1987) 2.69
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther (2009) 2.41
Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms. Am J Dis Child (1990) 2.30
Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS (2001) 2.28
Patterns of disclosure and perceptions of the human immunodeficiency virus in infected elementary school-age children. Arch Pediatr Adolesc Med (1997) 2.14
The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis. Aliment Pharmacol Ther (2013) 2.01
Infection of brain-derived cells with the human immunodeficiency virus. J Virol (1987) 2.01
Influence of cholesterol on phospholipid bilayers phase domains as detected by Laurdan fluorescence. Biophys J (1994) 1.93
The neuropathogenesis of HIV-1 infection. J Leukoc Biol (1994) 1.83
CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis. Neurology (2012) 1.80
Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function. J Clin Invest (1980) 1.68
A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. AIDS Res Hum Retroviruses (1987) 1.67
Relapse of herpes simplex encephalitis. J Child Neurol (1995) 1.66
Identification of a hemagglutinin-specific idiotype associated with reovirus recognition shared by lymphoid and neural cells. J Exp Med (1982) 1.64
Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2000) 1.63
Establishment of human microglial cell lines after transfection of primary cultures of embryonic microglial cells with the SV40 large T antigen. Neurosci Lett (1995) 1.63
Isolation of human immunodeficiency virus (HIV) from plasma during primary HIV infection. J Med Virol (1987) 1.61
Discrimination between antibodies to HIV and to related retroviruses using site-directed serology. Nature (1987) 1.59
FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J Neurosci (1999) 1.58
MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum Mol Genet (2000) 1.58
Cholesterol modifies water concentration and dynamics in phospholipid bilayers: a fluorescence study using Laurdan probe. Biophys J (1994) 1.57
Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood (1997) 1.49
The course and outcome of unilateral intracranial arteriopathy in 79 children with ischaemic stroke. Brain (2008) 1.45
Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol (1999) 1.43
Low-dose zidovudine in children with an human immunodeficiency virus type 1 infection acquired in the perinatal period. Pediatrics (1991) 1.41
Interaction of viruses with cell surface receptors. Int Rev Cytol (1982) 1.40
Viral receptors on isolated murine and human ependymal cells. Science (1982) 1.37
Neuropathology of early HIV-1 infection. Brain Pathol (1996) 1.37
Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. J Immunol (1999) 1.34
Intrathecal synthesis of different alpha-interferons in patients with various neurological diseases. Acta Neurol Scand (1985) 1.34
HIV antigenaemia and virus isolation from plasma during primary HIV infection. Lancet (1987) 1.33
Primary in vitro antibody response from human peripheral blood lymphocytes. J Immunol (1977) 1.30
Age dependent susceptibility to Reovirus type 3 encephalitis: role of viral and host factors. Ann Neurol (1983) 1.29
Detection of measles virus RNA in lymphocytes from peripheral-blood and brain perivascular infiltrates of patients with subacute sclerosing panencephalitis. N Engl J Med (1985) 1.29
Human microglial cells: characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection. Ann Neurol (1991) 1.26
Vein of Galen malformation. Endovascular management of 43 cases. Childs Nerv Syst (1991) 1.26
Hydrodynamics in vein of Galen malformations. Childs Nerv Syst (1992) 1.25
V3 sequences of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of disease. Virology (1993) 1.24
The biological phenotype of HIV-1 is usually retained during and after sexual transmission. Virology (1994) 1.23
Primary in vitro antibody response of human peripheral blood lymphocytes: role of phagocytic mononuclear cells. J Immunol (1978) 1.23
Is a dissection balloon beneficial in totally extraperitoneal endoscopic hernioplasty (TEP)? A randomized prospective multicenter study. Surg Endosc (2001) 1.22
Stroke in childhood: outcome and recurrence risk by mechanism in 59 patients. J Child Neurol (2000) 1.22
Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France. Neurology (1996) 1.21
Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis. Mult Scler (2011) 1.20
Neonatal susceptibility to MHV3 infection in mice. II. Role of natural effector marrow cells in transfer of resistance. J Immunol (1980) 1.17
The expression of thyrotropin receptor in the brain. Endocrinology (2001) 1.14
The effects of 1-year gluten withdrawal on bone mass, bone metabolism and nutritional status in newly-diagnosed adult coeliac disease patients. Aliment Pharmacol Ther (2000) 1.14
Increased antigen and bacterial uptake in follicle associated epithelium induced by chronic psychological stress in rats. Gut (2004) 1.13
Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection--correlation with clinical progression, viral load, and loss of humoral immunity. Virology (1997) 1.12
Influence of pattern of clinical presentation and of gluten-free diet on bone mass and metabolism in adult coeliac disease. Bone (1996) 1.11
Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection. Virology (1993) 1.11
Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons. Ann Neurol (1997) 1.11
Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children. Mult Scler (2010) 1.11
Transient cerebral arteriopathy: a disorder recognized by serial angiograms in children with stroke. J Child Neurol (1998) 1.10
Improved tissue culture technique for production of poorly replicating human immunodeficiency virus strains. J Virol Methods (1988) 1.09
Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors. Virology (1999) 1.09
Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity. Proc Natl Acad Sci U S A (1991) 1.08
Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1. AIDS (1989) 1.08
Low levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome encephalopathy. Am J Pathol (1992) 1.08
Bone metabolism in type 2 diabetes mellitus. Acta Diabetol (1999) 1.08
Captopril and immune regulation. Kidney Int (1984) 1.07
Anti-Fas IgG1 antibodies recognizing the same epitope of Fas/APO-1 mediate different biological effects in vitro. Int Immunol (1997) 1.06
Suppressor cell function after intravenous gammaglobulin treatment in adult chronic idiopathic thrombocytopenic purpura. Br J Haematol (1985) 1.05
HIV type 1 V3 sequences and the development of dementia during AIDS. AIDS Res Hum Retroviruses (1996) 1.05
Biological phenotype of HIV type 2 isolates correlates with V3 genotype. AIDS Res Hum Retroviruses (1996) 1.04
Progressive B cell apoptosis and expression of Fas ligand during human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses (1997) 1.04
Effects of potassium citrate supplementation on bone metabolism. Calcif Tissue Int (2004) 1.03
Virus-binding receptors: similarities to immune receptors as determined by anti-idiotypic antibodies. Surv Immunol Res (1982) 1.03
DSM-IV mental disorders and neurological complications in children and adolescents with human immunodeficiency virus type 1 infection (HIV-1). Eur Psychiatry (2004) 1.03
HIV-1 envelope proteins gp120 and gp160 potentiate NMDA-induced [Ca2+]i increase, alter [Ca2+]i homeostasis and induce neurotoxicity in human embryonic neurons. Eur J Neurosci (1995) 1.03
Acute and persistent infection of human neural cell lines by human coronavirus OC43. J Virol (1999) 1.02
Enhancement of human immunodeficiency virus (HIV) replication in human monocytes by low titres of anti-HIV antibodies in vitro. Scand J Immunol (1989) 1.02
Parental origin of de novo MECP2 mutations in Rett syndrome. Eur J Hum Genet (2001) 1.01
Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment. J Clin Microbiol (1995) 1.01
Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide. Growth Factors (1994) 1.01
Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis. Dig Dis Sci (2000) 1.00
Biological correlates of HIV-1 heterosexual transmission. AIDS (1997) 1.00
Segregation of a totally skewed pattern of X chromosome inactivation in four familial cases of Rett syndrome without MECP2 mutation: implications for the disease. J Med Genet (2001) 1.00
Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding. New Microbiol (2000) 0.99
Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects. Clin Exp Immunol (2002) 0.99
Microdeletion at chromosome 4q21 defines a new emerging syndrome with marked growth restriction, mental retardation and absent or severely delayed speech. J Med Genet (2010) 0.98
Autosomal dominant deletions of the mitochondrial genome in a case of progressive encephalomyopathy. Am J Hum Genet (1991) 0.98
In vitro production of IL-6, IL-1 beta, and tumor necrosis factor-alpha by human embryonic microglial and neural cells. J Immunol (1993) 0.98
Mastoiditis, meningitis and venous sinus thrombosis caused by Fusobacterium necrophorum. Eur J Pediatr (1994) 0.98
Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E. J Virol (1999) 0.97
Depressed primary in vitro antibody response in rheumatoid arthritis. Clin Exp Immunol (1979) 0.97
Two neutralizing domains in the V3 region in the envelope glycoprotein gp125 of HIV type 2. J Immunol (1994) 0.96
HIV induces IL-6 production by human B lymphocytes. Role of IL-4. J Immunol (1992) 0.96
Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study. Scand J Infect Dis (1994) 0.95
Hemispheric control of unilateral and bilateral movements of proximal and distal parts of the arm as inferred from simple reaction time to lateralized light stimuli in man. Exp Brain Res (1980) 0.95